BOSTON, Oct. 17 /PRNewswire-FirstCall/ -- NMT Medical, Inc. , an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat cardiac sources of migraine headaches, stroke and other potential brain attacks, today announced that NMT’s executive management will provide an update on the Company at the following investor conferences:
* C.E. Unterberg, Towbin Emerging Opportunities in Health Care Conference at The New York Palace Hotel, October 30, 2006 at 11:00 a.m. (ET), * CIBC World Markets 17th Annual Healthcare Conference at The Waldorf-Astoria in New York City, November 7, 2006 at 4:10 p.m. (ET).
Presenting for NMT Medical will be President and Chief Executive Officer John E. Ahern. He will be accompanied by Vice President and Chief Financial Officer Richard E. Davis. NMT’s presentations will be broadcast live over the Internet. Individuals who are interested in listening to the webcasts should log on to the “Investor Relations” section of NMT Medical’s website at http://www.nmtmedical.com. For those unable to listen to the live broadcasts, a replay of each presentation will be available on the Company’s website for approximately 90 days following the event.
About NMT Medical, Inc.
NMT Medical is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures. NMT Medical is currently investigating the potential connection between a common cardiac defect called a PFO and brain attacks such as migraine headaches, stroke and transient ischemic attacks (TIAs). A PFO can allow venous blood, unfiltered and unmanaged by the lungs, to enter the arterial circulation of the brain, possibly triggering a cerebral event or brain attack. More than 21,000 PFOs have been treated globally with NMT’s minimally invasive, catheter-based implant technology. The prevalence of migraines in the United States is about 10%. Of the 28 million migraine sufferers in America, those who experience aura and have a PFO may represent a three million patient subset. Stroke is the third leading cause of death in the United States and the leading cause of disability in adults. Each year, 750,000 Americans suffer a new or recurrent stroke and an additional 500,000 Americans experience a TIA.
For more information about NMT Medical, please visit http://www.nmtmedical.com. Contact: Richard E. Davis Chief Financial Officer NMT Medical, Inc. (617) 737-0930 red@nmtmedical.com
NMT Medical, Inc.
CONTACT: Richard E. Davis, Chief Financial Officer of NMT Medical, Inc.,+1-617-737-0930, red@nmtmedical.com
Web site: http://www.nmtmedical.com/
